Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nicotinamide and metabolic pathways in early idiopathic Parkinson's disease
2004-005034-39Phase 4Unknown
- Sponsor
- Queen Elizabeth Hospital
- Start
- Apr 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of nicotinamide in Parkinson's disease (PD) (2 arms), sponsored by Queen Elizabeth Hospital. Primary endpoints: N-methyl nicotinamide levels in urine and ATP complex I activity in blood. Status: unknown.
02
Drugs
nicotinamide
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on 2004-005034-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-005034-39.